Does Candida albicans Als5p amyloid play a role in commensalism in Caenorhabditis elegans?

Eukaryotic Cell

Volumn 12, Issue 5, 2013, Pages 703-711

  Bois, Michael ^a,b   Singh, Sean ^a,b   Samlalsingh, Alyssa ^b   Lipke, Peter N ^a,b   Garcia, Melissa C ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALA1 PROTEIN, CANDIDA ALBICANS; AMYLOID; CELL ADHESION MOLECULE; FUNGAL PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CELL ADHESION; CYTOLOGY; GENETICS; HOST PATHOGEN INTERACTION; INTESTINE; METABOLISM; MICROBIOLOGY; OOCYTE; OOCYTE DEVELOPMENT; PATHOGENICITY; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE;

AMYLOID; ANIMALS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CELL ADHESION; CELL ADHESION MOLECULES; FUNGAL PROTEINS; HOST-PATHOGEN INTERACTIONS; INTESTINES; OOCYTES; OOGENESIS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; FUNGI; NEMATODA; SACCHAROMYCES CEREVISIAE;

EID: 84876883413     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00020-13     Document Type: Article

References (41)

1. Hube B. 2004. From commensal to pathogen: stage-and tissue-specific gene expression of Candida albicans. Curr. Opin. Microbiol. 7:336-341.
2. Richard ML, Plaine A. 2007. Comprehensive analysis of glycosylphosphatidylinositol-anchored proteins in Candida albicans. Eukaryot. Cell 6:119-133.
3. Yang YL. 2003. Virulence factors of Candida species. J. Microbiol. Immunol. Infect. 36:223-228.
4. Hoyer LL. 2001. The ALS gene family of Candida albicans. Trends Microbiol. 9:176-180.
5. Gaur NK, Klotz SA. 1997. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect. Immun. 65:5289-5294.
6. Sheppard DC, Yeaman MR, Welch WH, Phan QT, Fu Y, Ibrahim AS, Filler SG, Zhang M, Waring AJ, Edwards JE, Jr. 2004. Functional and structural diversity in the Als protein family of Candida albicans. J. Biol. Chem. 279:30480-30489.
7. Otoo HN, Lee KG, Qiu W, Lipke PN. 2008. Candida albicans Als adhesins have conserved amyloid-forming sequences. Eukaryot. Cell 7:776-782.
8. Ramsook CB, Tan C, Garcia MC, Fung R, Soybelman G, Henry R, Litewka A, O'Meally S, Otoo HN, Khalaf RA, Dranginis AM, Gaur NK, Klotz SA, Rauceo JM, Jue CK, Lipke PN. 2010. Yeast cell adhesion molecules have functional amyloid-forming sequences. Eukaryot. Cell 9:393-404.
9. Frank AT, Ramsook CB, Otoo HN, Tan C, Soybelman G, Rauceo JM, Gaur NK, Klotz SA, Lipke PN. 2010. Structure and function of glycosylated tandem repeats from Candida albicans Als adhesins. Eukaryot. Cell 9:405-414.
10. Rauceo JM, De Armond R, Otoo H, Kahn PC, Klotz SA, Gaur NK, Lipke PN. 2006. Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p. Eukaryot. Cell 5:1664-1673.
11. Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrene YF, Lipke PN. 2011. A role for amyloid in cell aggregation and biofilm formation. PLoS One 6:e17632. doi:10.1371/journal.pone.0017632.
12. Alsteens D, Garcia MC, Lipke PN, Dufrene YF. 2010. Force-induced formation and propagation of adhesion nanodomains in living fungal cells. Proc. Natl. Acad. Sci. U. S. A. 107:20744-20749.
13. Lipke PN, Garcia MC, Alsteens D, Ramsook CB, Klotz SA, Dufrene YF. 2012. Strengthening relationships: amyloids create adhesion nanodomains in yeasts. Trends Microbiol. 20:59-65.
14. Mylonakis E, Casadevall A, Ausubel FM. 2007. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog. 3:e101. doi:10.1371/journal.ppat.0030101.
15. Means TK. 2010. Fungal pathogen recognition by scavenger receptors in nematodes and mammals. Virulence 1:37-41.
16. Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206:637-653.
17. Tenor JL, Aballay A. 2008. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep. 9:103-109.
18. Komura T, Yasui C, Miyamoto H, Nishikawa Y. 2010. Caenorhabditis elegans as an alternative model host for Legionella pneumophila, and protective effects of Bifidobacterium infantis. Appl. Environ. Microbiol. 76: 4105-4108.
19. Anyanful A, Easley KA, Benian GM, Kalman D. 2009. Conditioning protects C. elegans from lethal effects of enteropathogenic E. coli by activating genes that regulate lifespan and innate immunity. Cell Host Microbe 5:450-462.
20. Matricardi PM. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'. Clin. Exp. Immunol. 160:98-105.
21. Pujol N, Zugasti O, Wong D, Couillault C, Kurz CL, Schulenburg H, Ewbank JJ. 2008. Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog. 4:e1000105. doi:10.1371/journal.ppat.1000105.
22. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. 2006. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2:e183. doi:10.1371/journal.pgen.0020183.
23. Jain C, Yun M, Politz SM, Rao RP. 2009. A pathogenesis assay using Saccharomyces cerevisiae and Caenorhabditis elegans reveals novel roles for yeast AP-1, Yap1, and host dual oxidase BLI-3 in fungal pathogenesis. Eukaryot. Cell 8:1218-1227.
24. Sifri CD, Begun J, Ausubel FM. 2005. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13:119-127.
25. Keppler-Ross S, Noffz C, Dean N. 2008. A new purple fluorescent color marker for genetic studies in Saccharomyces cerevisiae and Candida albicans. Genetics 179:705-710.
26. Stiernagle T. 11 February 2006. Maintenance of C. elegans. WormBook 2006:1-11. doi:10.1895/wormbook.1.101.1.
27. Nicholas HR, Hodgkin J. 2004. Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans. Mol. Immunol. 41:479-493.
28. Rae R, Witte H, Rodelsperger C, Sommer RJ. 2012. The importance of being regular: Caenorhabditis elegans and Pristionchus pacificus defecation mutants are hypersusceptible to bacterial pathogens. Int. J. Parasitol. 42:747-753.
29. Twumasi-Boateng K, Shapira M. 2012. Dissociation of immune responses from pathogen colonization supports pattern recognition in C. elegans. PLoS One 7:e35400. doi:10.1371/journal.pone.0035400.
30. McGhee JD. 27 March 2007. The C. elegans intestine. WormBook 2007: 1-36. doi:10.1895/wormbook.1.133.1.
31. Seidel HS, Kimble J. 2011. The oogenic germline starvation response in C. elegans. PLoS One 6:e28074. doi:10.1371/journal.pone.0028074.
32. Lorenzo A, Yankner BA. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U. S. A. 91:12243-12247.
33. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-241.
34. Cottier F, Pavelka N. 2012. Complexity and dynamics of host-fungal interactions. Immunol. Res. 53:127-135.
35. Oli MW, Otoo HN, Crowley PJ, Heim KP, Nascimento MM, Ramsook CB, Lipke PN, Brady LJ. 18 October 2012. Functional amyloid formation by Streptococcus mutans. Microbiology doi:10.1099/mic.0.060855-0.
36. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. 2007. Semenderived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071.
37. Fowler DM, Koulov AV, Balch WE, Kelly JW. 2007. Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32:217-224.
38. Mochon AB, Jin Y, Kayala MA, Wingard JR, Clancy CJ, Nguyen MH, Felgner P, Baldi P, Liu H. 2010. Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia. PLoS Pathog. 6:e1000827. doi:10.1371/journal.ppat.1000827.
39. Cheng G, Wozniak K, Wallig MA, Fidel PL, Jr, Trupin SR, Hoyer LL. 2005. Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis. Infect. Immun. 73:1656-1663.
40. Gilchrist KB, Garcia MC, Sobonya R, Lipke PN, Klotz SA. 2012. New features of invasive candidiasis in humans: amyloid formation by fungi and deposition of serum amyloid P component by the host. J. Infect. Dis. 206:1473-1478.
41. Pepys MB. 2012. Invasive candidiasis: new insights presaging new therapeutic approaches? J. Infect. Dis. 206:1339-1341.